La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl P...

FDA Drug Recall #D-0417-2025 — Class II — March 5, 2025

Recall Summary

Recall Number D-0417-2025
Classification Class II — Moderate risk
Date Initiated March 5, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm L'Oreal USA
Location Clark, NJ
Product Type Drugs
Quantity 2,226,801 bottles

Product Description

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.

Reason for Recall

Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot #: MYX46W, Exp 04/30/2025

Other Recalls from L'Oreal USA

Recall # Classification Product Date
D-0419-2025 Class II La Roche-Posay Laboratoire Dermatologique Effac... Mar 5, 2025
D-0418-2025 Class II La Roche-Posay Laboratoire Dermatologique Effac... Mar 5, 2025

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.